SEC Form 4 · accession 0001613377-18-000011
AIM ImmunoTech Inc. · AIM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William M Mitchell
Director
Period of report
May 16, 2018
Accepted (ET)
May 18, 2018 · 12:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000946644
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Options to buy Common StockF1 | $0.30 | May 16, 2018 | A | 152,053 | A | May 16, 2018 | May 16, 2028 | Common Stock | 152,053 | 152,053 | D |
| Options to buy Common StockF2 | $0.30 | May 16, 2018 | A | 100,000 | A | May 16, 2018 | May 16, 2028 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1This option is being issued to senior management for a voluntary 100% deferral of Directors fees.
- F2This option was awarded by the Board of Directors for serving as chairman of various committees.